Insiders · Profile

Notman Donald

Chief Operating Officer at OCULAR THERAPEUTIX. Filing since 7 Dec 2017. CIK 0001718019

Company

Date

Role

Action

Shares

Amount

Of holding

OCUL OCULAR THERAPEUTIX, INC

31 Aug 2026

Chief Operating Officer

Sold at will

1,099

$11.25K

0.3%

OCUL OCULAR THERAPEUTIX, INC

12 Feb 2026

Chief Operating Officer

Sold at will

11,446

$103.47K

3.0%

OCUL OCULAR THERAPEUTIX, INC

4 Feb 2026

Chief Operating Officer

Sold at will

6,035

$51.54K

1.6%

OCUL OCULAR THERAPEUTIX, INC

2 Feb 2026

Chief Operating Officer

Sold at will

5,455

$49.86K

1.4%

OCUL OCULAR THERAPEUTIX, INC

2 Sep 2025

See Remarks

Sold at will

1,066

$13.25K

0.3%

OCUL OCULAR THERAPEUTIX, INC

4 Feb 2025

See Remarks

Sold at will

11,119

$86.84K

5.4%

OCUL OCULAR THERAPEUTIX, INC

31 Jan 2025

See Remarks

Sold at will

6,301

$49.40K

3.0%

OCUL OCULAR THERAPEUTIX, INC

5 Feb 2024

Chief Financial Officer

Bought

6,212

$30.19K

3.3%

OCUL OCULAR THERAPEUTIX, INC

31 Jan 2024

Chief Financial Officer

Sold at will

6,433

$31.84K

4.4%

OCUL OCULAR THERAPEUTIX, INC

6 Feb 2023

Chief Financial Officer

Sold, plan not stated

6,476

$27.46K

4.4%

OCUL OCULAR THERAPEUTIX, INC

14 Jun 2019

Chief Financial Officer

Bought

2,500

$10.83K

11.6%

OCUL OCULAR THERAPEUTIX, INC

14 Aug 2018

Chief Financial Officer

Bought

12,500

$78.63K

260%

OCUL OCULAR THERAPEUTIX, INC

7 Dec 2017

Chief Financial Officer

Bought

4,800

$19.20K

opened

13 decisions on file.